The NeuroCircuit logo
The NeuroCircuit
Reading List
Subscribe
  • The NeuroCircuit
  • Topics
  • Neurotech News

Neurotech News

Weekly insights and discoveries shaping the future of brain science.

Brain-to-VoiceClosed-loop DBSNeurotechnologyNeurohackingEthics & PolicyNeurorehabilitation & RoboticsNeuroscienceNeuralink Gene & Cell Therapies in NeurotechClinical Trial NewsIndustry & Leadership UpdatesBrain-Computer Interfaces (BCI)Sensory VR & BCIsNeural EngineeringEmerging TechNeurotech NewsNeural ImplantsInnovationDIY Neuro
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 40 | The First Signal of 2026
Jan 11, 2026

Weekly Signal: 40 | The First Signal of 2026

Foundations, funding, and clarity

Ricardo Albornoz
NeurotechnologyNeurotechnology
+5+5
Weekly Signal: 39 | Clinical Proof, Clearer Signals
Dec 28, 2025

Weekly Signal: 39 | Clinical Proof, Clearer Signals

Neuromodulation and measurement advance

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 38 | When BCIs Leave the Lab
Dec 21, 2025

Weekly Signal: 38 | When BCIs Leave the Lab

Regulation, reality, deployment

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data
Nov 30, 2025

Weekly Signal: 35 | Ultrasound, BCIs, and the Battle for Brain Data

Breakthroughs in Brain Signals and Safety

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 32 | Tiny Implants, Big Governance
Nov 08, 2025

Weekly Signal: 32 | Tiny Implants, Big Governance

Miniaturized BCIs & Global Neuro-Ethics

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights
Nov 01, 2025

Weekly Signal: 31 | FcRn Trials, Neuromodulation Breakthroughs, and Neuro-Rights

Clinical data, funding moves, and policy shifts

Ricardo Albornoz
Closed-loop DBSClosed-loop DBS
+6+6
Weekly Signal: 27 | BCI Gains, DBS Updates & Policy
Oct 04, 2025

Weekly Signal: 27 | BCI Gains, DBS Updates & Policy

Clinical signals, market moves

Ricardo Albornoz
Brain-to-VoiceBrain-to-Voice
+6+6
Weekly Signal: 25 | Imagined Speech & Neuromod Breakthroughs
Sep 20, 2025

Weekly Signal: 25 | Imagined Speech & Neuromod Breakthroughs

BCI Trials and Industry Milestones

Ricardo Albornoz
NeurotechnologyNeurotechnology
+6+6
Weekly Signal: 24 | Therapies, Tracers & Tech Shifts
Sep 13, 2025

Weekly Signal: 24 | Therapies, Tracers & Tech Shifts

Clinical wins & data rules

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+5+5
Weekly Signal: 23 | Neurotech on the Edge: BCI Breakthroughs
Sep 07, 2025

Weekly Signal: 23 | Neurotech on the Edge: BCI Breakthroughs

Privacy, Therapy & Beyond

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+3+3
Weekly Signal: 21 | Noninvasive Neuromodulation Steps Forward
Aug 23, 2025

Weekly Signal: 21 | Noninvasive Neuromodulation Steps Forward

Graphene control, FDA wins

Ricardo Albornoz
Ethics & PolicyEthics & Policy
+6+6
Weekly Signal 19 — Brain Models, Consciousness Probes & Neuro-Policy Shifts
Aug 10, 2025

Weekly Signal 19 — Brain Models, Consciousness Probes & Neuro-Policy Shifts

From lab breakthroughs to policy battles shaping neurotech’s future.

Ricardo Albornoz
The NeuroCircuit delivers cutting-edge neurotechnology news, insights, and tools straight to the minds shaping the future.

The NeuroCircuit

The NeuroCircuit delivers cutting-edge neurotechnology news, insights, and tools straight to the minds shaping the future.

Home

Posts

NeuroCircuit Reading List

Reading List

© 2026 The NeuroCircuit.

Privacy policy

Terms of use

Powered by beehiiv